HDAC4
Drug & target - TTD
NameType of TargetSynonymsDiseaseDrugsInhibitorAntibody
Histone deacetylase 4Successful targetHDAC4Acne vulgaris;Bladder cancer;Cutaneous T-cell lymphoma;Renal cell carcinoma;Hormone refractory prostate cancer;Solid tumors;Colorectal cancer;Pancreatic cancer;Myeloid leukemia;Lymphoid leukemia;Mesothelioma;Liver cancers;Skin cancer;Basal cell carcinoma;Ovarian cancer;Prostate cancer;Lymphoma;Melanoma; Prostate cancer;Multiple myeloma;Myelodisplastic syndrome;SarcomaFK-228N-(5-Hydroxycarbamoyl-pentyl)-4-nitro-benzamide;6-Phenoxy-hexane-1-thiol;N-Hydroxy-4-(4-phenyl-butyrylamino)-benzamide;(E)-8-Biphenyl-4-yl-1-oxazol-2-yl-oct-7-en-1-one;Cyclo(-L-Am7(S2Py)-D-2MePhe-L-Ala-D-Pro-);N-hydroxy-9,10-dihydroanthracene-9-carboxamide;6-phenylsulfanylhexanoic acid hydroxamide;Cyclo(-L-Am7(S2Py)-A2in-L-Ala-D-Pro-);AZUMAMIDE C;7-(Biphenyl-4-yloxy)-1,1,1-trifluoro-heptan-2-one;santacruzamate A;N-hydroxy-2,2-diphenylacetamide;8-Oxo-8-phenyl-octanoic acid;N-Hydroxy-4-(2-phenyl-butyrylamino)-benzamide;Cyclo(-L-Am7(S2Py)-L-A1in-L-Ala-D-Pro-);7-(Biphenyl-3-yloxy)-1-oxazol-2-yl-heptan-1-one;5-(4-Chloro-phenyl)-pentanoic acid hydroxyamide;2,2-bis(3-fluorophenyl)-N-hydroxyacetamide;7-Mercapto-heptanoic acid phenylamide;5-(4-hydroxyphenyl)-3H-1,2-dithiole-3-thione;N-Hydroxy-4-((R)-2-phenyl-butyrylamino)-benzamide;Octanedioic acid hydroxyamide pyridin-2-ylamide;Cyclo(-L-Am7(S2Py)-Aib-L-Phg-D-Pro-);PSAMMAPLIN A;TMP269;7-Mercapto-heptanoic acid pyridin-3-ylamide;N-Hydroxy-4-phenylacetylamino-benzamide;4-Benzoylamino-N-hydroxy-benzamide;9,9,9-Trifluoro-8-oxo-nonanoic acid phenylamide;Cyclo(-L-Am7(S2Py)-Aib-L-Ph4-D-Pro-);N-hydroxy-9H-xanthene-9-carboxamide;6-benzenesulfonylhexanoic acid hydroxamide;8-Oxo-8-phenyl-octanoic acid hydroxyamide;9-(Biphenyl-4-yloxy)-1,1,1-trifluoro-nonan-2-one;N-(2-Mercapto-ethyl)-N'-phenyl-succinamide;LARGAZOLE;Cyclo(-L-Am7(S2Py)-Aib-L-Phe-D-Pro-);4-Dimethylamino-N-(6-mercapto-hexyl)-benzamide;ST-2987;Cyclo(-L-Am7(S2Py)-Aib-L-Ala-D-Tic-);Cyclo(-L-Am7(S2Py)-D-A1in-L-Ala-D-Pro-);N-Hydroxy-4-((S)-2-phenyl-butyrylamino)-benzamide;N-(2-Mercapto-ethyl)-N'-phenyl-oxalamide;N-Hydroxy-4-(pentanoylamino-methyl)-benzamide;7-Mercapto-heptanoic acid quinolin-3-ylamide;Cyclostellettamine derivative;Cyclo(-L-Am7(S2Py)-Aib-L-Ser-D-Pro-);8-(Biphenyl-4-yloxy)-1,1,1-trifluoro-octan-2-one;N-hydroxy-2,2-diphenylpropanamide;Cyclo(-L-Am7(S2Py)-Aib-L-Ala-D-Pro-);Octanedioic acid hydroxyamide pyridin-4-ylamide;Thioacetic acid S-(6-phenylcarbamoyl-hexyl) ester;4-Hydroxy-N-(5-hydroxycarbamoyl-pentyl)-benzamide;7-(Naphthalen-2-yloxy)-1-oxazol-2-yl-heptan-1-one;7-(Biphenyl-4-yloxy)-1-oxazol-2-yl-heptan-1-one;ST-3050;N-(6-Hydroxycarbamoyl-hexyl)-benzamide;7-Mercapto-heptanoic acid biphenyl-3-ylamide;2,2-bis(4-fluorophenyl)-N-hydroxyacetamide;6-(2-Bromo-acetylamino)-hexanoic acid phenylamide;6-Mercapto-hexanoic acid phenylamide;Cyclo(-L-Am7(S2Py)-Aib-L-Ph5-D-Pro-);Octanedioic acid bis-hydroxyamide;4-Chloro-N-(5-hydroxycarbamoyl-pentyl)-benzamide;7-Mercapto-heptanoic acid biphenyl-4-ylamide;N-Hydroxy-4-(5-phenyl-pentanoylamino)-benzamide;8-Mercapto-octanoic acid phenylamide;N-Hydroxy-4-(phenylacetylamino-methyl)-benzamide;7-Mercapto-heptanoic acid benzothiazol-2-ylamide;N-(6-Mercapto-hexyl)-benzamide;Cyclo(-L-Am7(S2Py)-Aib-L-Ser(Bzl)-D-Pro-);7-mercapto-N-(4-phenylthiazol-2-yl)heptanamide;AZUMAMIDE B;2-(methylsulfonylthio)ethyl 2-propylpentanoate;5-Mercapto-pentanoic acid phenylamide;6-benzenesulfinylhexanoic acid hydroxamide;4-Butyrylamino-N-hy
Histone deacetylase-4Research targetHistone deacetylase 4;HD4;HDAC4Huntington's disease
Drug & target - GRAC
histone deacetylase 4 enzyme 848 3.5.1.- Histone deacetylases (HDACs) 2659 2q37.3